Novel Psychoactive Substances

Erscheinungsjahr 2013
ISBN: 978-0-12-415816-0
Verlag: ACADEMIC PRESS

Buch, Englisch, 440 Seiten, Format (B × H): 199 mm x 244 mm, Gewicht: 1100 g

Novel Psychoactive Substances: Classification, Pharmacology and Toxicology provides readers with background on the classification, detection, supply and availability of novel psychoactive substances, otherwise known as "legal highs." This book also covers individual classes of novel psychoactive substances that have recently emerged onto the recreational drug scene and provides an overview of the pharmacology of the substance followed by a discussion of the acute and chronic harm or toxicity associated with the substance. Written by international experts in the field, this multi-authored book is a valuable reference for scientists, clinicians, academics, and regulatory and law enforcement professionals.

Zielgruppe

<p>Research scientists and academics in pharmacology and toxicology, biochemists and healthcare professionals, including physicians, nurses and paramedics, law enforcement and legislative authorities. </p>

Autoren/Hrsg.

Dargan, Paul

Dargan, Paul I.

Wood, David M.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Neuropharmakologie, Psychopharmakologie

Inhaltsverzeichnis

Section 1: Background1. Legal Classification of Novel Psychoactive Substances: An International Comparison2. Monitoring novel psychoactive substances - a global perspective3. Availability and Supply of Novel Psychoactive Substances4. Epidemiology and Use of Novel Psychoactive Substances5. Social issues in the use of novel psychoactive substancesSection 2: Analytical Techniques6. Analytical techniques for the detection of novel psychoactive substances and their metabolitesSection 3: Individual Novel Psychoactive Substances7. Synthetic Amphetamines including novel MDMA analogues8. 1-benzylpiperazine and other piperazines9. 4-methylmethcathinone (mephedrone) and other synthetic cathinones10. Pipradrol and pripradrol derivatives11. Aminoindanes and related compounds12. Gamma-hydrogybutyrate and its analogues13. Ketamine14. Synthetic cannabinoid receptor agonists15. Herbal novel psychoactive substances 16. Tryptamines17. Benzodifurans18. Miscellaneous compounds

Über Autor(innen)

Dargan, Paul I.
Professor Dargan and Dr Wood are both expert advisors on novel psychoactive substances to expert bodies in the UK (Advisory Council on the Misuse of Drugs, ACMD), Europe (European Monitoring Centre for Drugs and Drug Addiction, EMCDDA) and Worldwide (United Nations Office on Drugs and Crime, UNODC). They run a clinical service managing patients with acute drug toxicity, and have a clinical and research interest in novel psychoactive substances. They publish widely in this field and have both been invited to give keynote lectures at International meetings on this topic.

Wood, David M.
David Wood is a Consultant Physician and Clinical Toxicologist at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.